Traditional DRD2 antagonists, such as Haloperidol and risperidone, are known for their efficacy in treating schizophrenia but are often associated with severe side effects, including extrapyramidal symptoms and metabolic disturbances [23]. Here, DRD2 is linked to schizophrenia.